Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Julphar
Federal Trade Commission
Covington
Medtronic
Daiichi Sankyo

Generated: May 25, 2019

DrugPatentWatch Database Preview

Iobenguane sulfate i-123 - Generic Drug Details

« Back to Dashboard

What are the generic sources for iobenguane sulfate i-123 and what is the scope of iobenguane sulfate i-123 freedom to operate?

Iobenguane sulfate i-123 is the generic ingredient in one branded drug marketed by Ge Healthcare and is included in one NDA. Additional information is available in the individual branded drug profile pages.

One supplier is listed for this compound.

Summary for iobenguane sulfate i-123
US Patents:0
Tradenames:1
Applicants:1
NDAs:1
Suppliers / Packagers: 1
Bulk Api Vendors: 5
Clinical Trials: 4
DailyMed Link:iobenguane sulfate i-123 at DailyMed
Synonyms for iobenguane sulfate i-123
((3-(Iodo-(sup 123)I)-phenyl)methyl)guanidine sulfate (2:1)
((3-IODO(123I)PHENYL)METHYL)GUANIDINE
(123)I-MIBG
(123I)-m-Iodobenzylguanidine
(m-Iodo-(sup 123)I-benzyl)guanidine sulfate (2:1)
(m-Iodo-(sup 123)I)-benzyl)guanidine sulfate (2:1)
123 iodine metaiodobenzylguanidine
123I-MIBG
139755-80-9
2-[(3-iodanylphenyl)methyl]guanidine
23X1185WBO
3-Iodobenzylguanidine (123I) (JAN)
76924-93-1
AC1L367T
AC1Q50E3
Adreview
CHEBI:135134
CHEMBL1615777
CHEMBL3989523
D01729
DB09546
Guanidine, ((3-(iodo-(sup 123)I)phenyl)methyl)-, sulfate (2:1)
Guanidine, ((3-iodo(123I)phenyl)methyl)-
Iobenguane (123I)
Iobenguane I 123
Iobenguane I 123 [USAN]
Iobenguane Sulfate (123I)
Iobenguane sulfate I 123
Iobenguane sulfate I 123 [USAN]
Iodine-123 metaiodobenzylguanidine
Iodobenzylguanidine Sulfate (123I)
m-(123I)Iodobenzylguanidine
m-Iodobenzylguanidine-123I
MIBG-I-123
MOLI000966
MyoMIBG-I 123 (TN)
P2TH1XYZ84
SCHEMBL13158600
UNII-23X1185WBO
UNII-P2TH1XYZ84

US Patents and Regulatory Information for iobenguane sulfate i-123

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ge Healthcare ADREVIEW iobenguane sulfate i-123 SOLUTION;INTRAVENOUS 022290-001 Sep 19, 2008 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Johnson and Johnson
Covington
McKesson
Accenture
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.